Innovaderm Research Expands into Rheumatology
Innovaderm Research, recognized for its expertise in dermatology, is thrilled to announce an important new addition to its team. Dr. Juan Gabriel Ovalles Bonilla, MD, PhD, an accomplished and board-certified rheumatologist, will be joining Innovaderm. His extensive experience brings added strength to the company’s efforts within the rheumatology field, demonstrating Innovaderm’s dedication to enhancing research and patient care for systemic autoimmune diseases.
Dr. Ovalles: A Valuable Addition to Innovaderm
Dr. Ovalles comes with over 12 years of clinical research experience, offering a rich knowledge base in both general and pediatric rheumatology. His involvement in esteemed professional organizations such as the Spanish Society of Rheumatology showcases his deep understanding of systemic immune-mediated diseases, inflammatory arthropathies, and juvenile rheumatic conditions. This wide-ranging skill set makes him a crucial asset in driving Innovaderm’s mission forward.
Insights from Dr. Bissonnette on Leadership
Dr. Robert Bissonnette, the CEO and Founder of Innovaderm, shared his excitement regarding Dr. Ovalles’s new role, saying, “We are thrilled to welcome Dr. Ovalles to Innovaderm Research. His expertise will be a tremendous asset to our team as we continue to advance our research and improve patient outcomes in both dermatology and rheumatology.” This statement highlights the significance of this strategic move for the organization's future.
The Increasing Demand for Specialized CROs
Innovaderm's decision to branch into rheumatology is a response to the growing need for specialized Contract Research Organizations (CROs) in this area. Due to the similarities in dermatology and rheumatology, Innovaderm is well-positioned to serve as a bridge between the two fields. With established relationships with essential medical professionals and clinical trial leaders in Europe, North America, LATAM, and APAC, Innovaderm is thoroughly equipped to deliver critical clinical, drug development, regulatory, and medical expertise across both areas.
Comprehensive Services Offered
At Innovaderm Research Inc., the emphasis is on both dermatology and rheumatology. The company provides support to biopharmaceutical sponsors throughout all phases of clinical trials, ensuring a comprehensive and high-quality process. As a leading specialized CRO, Innovaderm draws on over 25 years of acknowledged expertise in dermatology and clinical operations. This foundation is strengthened by a continually expanding network of clinicians, trial sites, and a dedicated research facility, all contributing to a thorough and holistic approach to specialized clinical needs.
Your Source for Rheumatology Information
If you’re interested in exploring Innovaderm's rheumatology resources, you’re encouraged to look deeper into their offerings. The combination of clinical insights and research expertise positions Innovaderm as a trustworthy partner in the ongoing study of autoimmune disorders.
Frequently Asked Questions
What is the key focus of Innovaderm Research?
Innovaderm Research focuses on dermatology and rheumatology, providing essential support in clinical trials for biopharmaceutical sponsors.
Who is Dr. Juan Gabriel Ovalles Bonilla?
Dr. Juan Gabriel Ovalles Bonilla is a board-certified rheumatologist with over 12 years of clinical research experience, recently appointed to Innovaderm Research.
What is a CRO?
A CRO, or Contract Research Organization, offers clinical trial support to biopharmaceutical companies, ensuring effective research and development processes.
What does Innovaderm aim to achieve in rheumatology?
Innovaderm aims to enhance research and improve patient outcomes in rheumatological care through its expansion into this specialized field.
How long has Innovaderm been in operation?
Innovaderm has over 25 years of experience in dermatology and clinical operations, making it a well-established name in clinical research.
